ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testopel ® vs. Generic Testosterone Pellets
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 190045" data-attributes="member: 13851"><p>[URL unfurl="true"]https://clinicaltrials.gov/ct2/show/NCT04523480[/URL]</p><p></p><p></p><p></p><p><strong>Sponsor:</strong> <span style="color: rgb(184, 49, 47)">University of Miami</span></p><p><strong>Collaborator:</strong> <span style="color: rgb(184, 49, 47)">Empower Pharmacy</span></p><p><strong>Information provided by (Responsible Party):</strong> <span style="color: rgb(184, 49, 47)">Ranjith Ramasamy, MD, University of Miami</span></p><p></p><p></p><p></p><p></p><p><strong>Brief Summary:</strong></p><p></p><p><span style="color: rgb(184, 49, 47)"><em>The purpose of this study is to evaluate changes in vascular parameters in subjects receiving Testopel 75mg (one time) versus subjects receiving Compounded Testosterone pellets 100mg (one time) versus subjects receiving Compounded Testosterone pellets 200mg (one time) to a participant with clinical hypogonadism.</em></span></p><p></p><p></p><p></p><p></p><p><strong>Detailed Description:</strong></p><p></p><p>Hypogonadism, or low testosterone (Low T), is the deficiency in producing testosterone by the testes. Testosterone pellets is a long-acting formulation of TRT that is delivered subcutaneously to men diagnosed with low T. Advantages to subcutaneous testosterone pellets include ease of delivery and decreased risk of the medication being transfer upon skin contact to woman or children. Long-acting testosterone replacement Implantation of six to ≥10 testosterone pellets (450 to ≥750 mg) increased total testosterone into the therapeutic range at 1-month post-implantation and sustained therapeutic levels (>300) for 4-6 months.</p><p></p><p>Participants will be randomly assigned to 1 of 3 study groups. In one of the groups, the treatment will include implantation of Testopel ® 750mg (10 pellets with 75mg pellet) one time, in the second group, treatment will include compounded subcutaneous testosterone 800mg (8 pellets with 100mg pellet) one time and in the third group, treatment will include compounded subcutaneous testosterone 800mg (4 pellets with 200mg pellet) one time.</p><p></p><p>The treatment takes approximately 30 minutes and will include: Clean and numb the insertion site with lidocaine at 1%, followed by a small incision in the skin, implantation of pellets into the subdermal fat layer, and sealing the incision with Steri-strip. This is the current standard of care of Testopel insertion and the same procedure will be followed with both compounded and commercial pellets.</p></blockquote><p></p>
[QUOTE="madman, post: 190045, member: 13851"] [URL unfurl="true"]https://clinicaltrials.gov/ct2/show/NCT04523480[/URL] [B]Sponsor:[/B] [COLOR=rgb(184, 49, 47)]University of Miami[/COLOR] [B]Collaborator:[/B] [COLOR=rgb(184, 49, 47)]Empower Pharmacy[/COLOR] [B]Information provided by (Responsible Party):[/B] [COLOR=rgb(184, 49, 47)]Ranjith Ramasamy, MD, University of Miami[/COLOR] [B]Brief Summary:[/B] [COLOR=rgb(184, 49, 47)][I]The purpose of this study is to evaluate changes in vascular parameters in subjects receiving Testopel 75mg (one time) versus subjects receiving Compounded Testosterone pellets 100mg (one time) versus subjects receiving Compounded Testosterone pellets 200mg (one time) to a participant with clinical hypogonadism.[/I][/COLOR] [B]Detailed Description:[/B] Hypogonadism, or low testosterone (Low T), is the deficiency in producing testosterone by the testes. Testosterone pellets is a long-acting formulation of TRT that is delivered subcutaneously to men diagnosed with low T. Advantages to subcutaneous testosterone pellets include ease of delivery and decreased risk of the medication being transfer upon skin contact to woman or children. Long-acting testosterone replacement Implantation of six to ≥10 testosterone pellets (450 to ≥750 mg) increased total testosterone into the therapeutic range at 1-month post-implantation and sustained therapeutic levels (>300) for 4-6 months. Participants will be randomly assigned to 1 of 3 study groups. In one of the groups, the treatment will include implantation of Testopel ® 750mg (10 pellets with 75mg pellet) one time, in the second group, treatment will include compounded subcutaneous testosterone 800mg (8 pellets with 100mg pellet) one time and in the third group, treatment will include compounded subcutaneous testosterone 800mg (4 pellets with 200mg pellet) one time. The treatment takes approximately 30 minutes and will include: Clean and numb the insertion site with lidocaine at 1%, followed by a small incision in the skin, implantation of pellets into the subdermal fat layer, and sealing the incision with Steri-strip. This is the current standard of care of Testopel insertion and the same procedure will be followed with both compounded and commercial pellets. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testopel ® vs. Generic Testosterone Pellets
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top